Biotechnology
Frost & Sullivan Publishes Q1 Update on Kadimastem
Continues its plans as expected; Ministry of Health approval for central experiment; financing is required to continue operations at the beginning of 2020; received Orphan Drug Designation from the FDA; target price unchanged. TEL AVIV, Israel, June 3, 2019 /PRNewswire/ -- The TASE analysis proje...
2019-06-03 21:24
1632
Chung Yuan Christian University plans to lead delegation of Taiwanese startups eyeing Australian market
TAIPEI, , June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event onMay 27, 2019. Over 10 internatio...
2019-06-03 10:24
5069
New NCCN Guidelines for Children with Cancer Meet Growing Needs of Pediatric Oncology Community Worldwide
New NCCN Guidelines® for Pediatric ALL include a strong focus on supportive care in order to reduce dangerous side-effects in children undergoing treatment for acute lymphoblastic leukemia, and share best practices for emerging treatments like immunotherapy, CAR T-cells, and targeted therapies. ...
2019-05-30 21:30
2304
Anpac Bio Presenting 'Unprecedented' Cerebral Cancer Liquid Biopsy Research Results at ASCO 2019
SACRAMENTO, California, May 30, 2019 /PRNewswire/ -- International life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio) Chief Executive Officer Dr.Chris Yu, announced today the company is presenting "unprecedented" cerebral cancer research results at theAmerican Society of Cl...
2019-05-30 20:00
3484
PENTAX Medical launches MILES FOR HEALTH(TM) campaign to celebrate the 100-year anniversary of its origin
TOKYO, May 29, 2019 /PRNewswire/ -- PENTAX Medical
2019-05-29 22:00
2862
Picosun Strengthens its Presence in the Healthcare Industries
ESPOO, Finland, May 29, 2019 /PRNewswire/ -- Picosun Group, the global provider of AGILE ALD™ (Atomic Layer Deposition) thin film coating solutions, continues its breakthrough into healthcare industries by supplying ALD technology to produce bioactive coatings on surgical implants at a major, lea...
2019-05-29 17:05
1178
CALECIM(R) forms a major partnership with Menarini Asia-Pacific to expand the presence of its stem cell skin care products in the region
SINGAPORE, May 27, 2019 /PRNewswire/ -- CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers...
2019-05-27 15:00
3525
EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF
Potential breakthrough technology for stem-cell based bone replacement NEW YORK, May 22, 2019 /PRNewswire/ -- EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of i...
2019-05-22 20:00
2900
CMAB Biopharma Announces Dr. Wang Yongzhong as CEO to Strengthen Leadership and Continue Business Expansion
SUZHOU, China and NEW YORK, May 20, 2019 /PRNewswire/ -- CMAB Biopharma Limited. (CMAB), a strict "pure-play" contract development and manufacturing organization (CDMO) focusing solely on services from sequence to commercial manufacturing for biologic products, has today announced the appointment...
2019-05-20 18:30
3766
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
SYDNEY, May 20, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cance...
2019-05-20 11:41
4120
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu
CHENGDU, China, May 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the construction of a new 1.3 million sq. ft....
2019-05-16 15:39
3850
Innovent Will Provide Key Results Update of Several Clinical Studies at 2019 ASCO Annual Meeting
SUZHOU, China, May 16, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...
2019-05-16 08:00
7975
Anpac Bio Gains U.S. CLIA Lab Certification
SACRAMENTO, California, May 16, 2019 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation,Anpac Bio-Medical Science Company (Anpac Bio), announced today that the company's United States subsidiary, Anpac TechnologyUSA, successfully passed the State of C...
2019-05-16 04:16
2298
Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1
HANGZHOU, China, May 15, 2019 /PRNewswire/ -- Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of1.5 billion yuan, according to the latest data of the Hangzhou Investment Promotion...
2019-05-15 20:56
3146
Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business
LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...
2019-05-15 03:11
2223
BGI Genomics and Pryzm Health Form Strategic Partnership to Advance Precision Public Health
SHENZHEN, China, May 14, 2019 /PRNewswire/ -- BGI Genomics and digital health start-up, Pryzm Health (Pryzm), signed a Memorandum of Understanding (MoU) today for collaboration to advance precision public health in Australia. With their complementary expertise and technology, BGI Genomics and Pr...
2019-05-14 17:04
4620
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony inSingapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis...
2019-05-14 12:15
9625
Brain imaging AI leader icometrix raises $18 million in new funding
Company's technology will transform care for patients with brain disorders and injuries LEUVEN, Belgium and GENEVA and BOSTON, May 14, 2019 /PRNewswire/ -- icometrix , the global expert in brain imaging Artificial Intelligence solutions, has raised$18 million through a partnership led by Forestay...
2019-05-14 08:00
3949
Frost & Sullivan Publishes Annual Update on BioLineRx
TEL AVIV, Israel, May 13, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure o...
2019-05-13 23:46
1184
MGI Announces US$200 Million in First Round Fundraising
SHENZHEN, China, May 13, 2019 /PRNewswire/ -- MGI, a subsidiary of BGI Group, has disclosed that its first round of fundraising exceededUS$200 million , the largest amount of capital raised in the genetic field inChina in 2018. Investors included well-known institutions such as CITIC Goldstone Cap...
2019-05-13 20:01
2597
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 276 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7855
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6951
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
5070